Navigation Links
Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia

BOZEN, Italy, February 23 /PRNewswire/ -- Health Robotics and Can-Med today announced that they have signed a definitive agreement whereby Can-Med has acquired the exclusive distribution rights to Health Robotics' i.v.STATION robot in Armenia, Georgia, Kazakhstan, Uzbekistan, Azerbaijan, Iran, Mongolia, Turkmenistan, Kyrgyzstan, and Tajikistan. i.v.STATION is the world's first and only automated, point-of-care-distributed, and fail-safe robotic system for the sterile and accurate preparation of non-hazardous intravenous medications. In consideration for the acquisition of i.v.STATION five years' exclusive distribution rights, Can-Med has issued Health Robotics with purchase orders for an additional 129 i.v.STATION robots.

The primary challenges in today's I.V. Admixture operations are serious medication errors, high costs, turn-around time, waste, regulatory issues, lack of audit trails, motion injuries, space constraints and difficulty in maintaining adequate and trained staff. i.v.STATION was designed to address these issues and overcome the fact that until now, the range of products and technology available to mitigate these challenges has consisted of variations on the IV "piggyback" bag, outsourcing of IVs, and partial robotic solutions that have seen very limited adoption and success.

"i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, and cost effective I.V. Admixtures. It offers unprecedented and life-critical patient safety, robotic precision and performance, all within a scalable and fail-safe architecture. We are committed to replicate the success of the CytoCare(TM) pay-per-use model with i.v.STATION beyond our home market in Turkey. The distributed nature of i.v.STATION permits its deployment where it matters most, at the direct patient care locations," stated Hilmi Sunay, General Manager of Can-Med I.V. Solutions.

"We are very pleased to expand our strategic partnership with Can-Med beyond our current operations in Turkey where I have personally witnessed the success of the pay-per-use model introduced by Can-Med for our CytoCare robot during the recent "go-live" at Ankara Oncology Hospital and endorsed on national television by the Turkish Minister of Health by encouraging Turkish hospitals to adopt our technology."


(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

"We continue to witness Health Robotics' global dominance in the area of non-hazardous IV Admixtures by logging in excess of 900 purchase orders for i.v.STATION within 8 months of its announcement, more than 30 times the total 10+ year sales volume of all our competitor's non-hazardous I.V. Robots combined. Especially on this tough global economic climate, the creativity that Can-Med has exhibited with its pay-per-use model has been demonstrated to yield unprecedented results for our business by eliminating the capital expenditures that hospitals face when torn between the demonstrated benefits of our robots and the difficult economic times we live in nowadays," stated Werner Rainer, CEO of Health Robotics.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing health care facilities around the world with robotic technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs] and i.v.STATION [non-hazardous IVs] have and will greatly contribute to ease global hospitals' & clinics' growing pressures to improve patient safety through effective and efficient production of sterile, safe, accurate, and ready-to-administer IVs, to decrease life-threatening medication errors and cross-contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain spiraling costs.

About Can-Med:

Can-Med is one of the leading I.V. solution providers in Turkey and parts of Eastern Europe, Middle East, and Central Asia. The company is the fastest growing business in Turkey within the fields of Pharmacy, I.V. Preparation and Administration, Oncology, Hemo-Dialysis, Periton-Dialisys, Diagnostic Testing, and Parenteral Nutrition. Can-Med has successfully introduced the world's first government-reimbursed pay-per-use model for robotic chemotherapy preparation and administration, with savings for both hospitals and the national government.

    For additional information, please contact:

    Health Robotics
    Gaspar G. DeViedma
    Europe: +39-346-963-4934
    USA: +1-609-980-7976

    Hilmi Sunay
    Turkey: +90-5325279678

SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
2. Jennifer Brownstein, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
3. Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health
4. 14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
5. Artemis Health Hires Richard Rava, Ph.D., as Senior Vice President of Research and Development
6. LAB research to present at upcoming UBS 2009 global healthcare services conference in New York
7. AMERIGROUP Praises Expansion of State Childrens Health Insurance Program (SCHIP)
8. BMP Sunstone to Present at UBS Global Healthcare Services Conference
9. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
10. Bluegiga Provides Health Device Profile for its Bluetooth OEM Modules
11. Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance
Post Your Comments:
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... IRVINE, Calif. , Oct. 8, 2015 ... announced its expansion into the North American market with ... Asia and Europe ... a pioneer of Target Enrichment methodology and sample preparation ... or NGS, facilitates both hereditary and somatic genetic testing ...
(Date:10/8/2015)... -- The ALS Association, in partnership with Prize4Life, is pleased ... communication technology solutions for people living with ALS. ... lateral sclerosis) is a progressive neurodegenerative disease that affects ... cord. Eventually, people with ALS lose the ability to ... total paralysis and death within two to five years ...
(Date:10/8/2015)... ... 08, 2015 , ... ProMIS Neurosciences, Inc. (TSX: PMN), announced ... commercialize intellectual property rights belonging to The University of British Columbia (UBC). This ... worldwide rights to intellectual property based on use of the ProMIS™ technology, modifications ...
Breaking Biology Technology:
... spotlight at the Institute of Physics Condensed Matter and Materials ... of London on 26-28 March. , The end ... has supplied several decades worth of remarkable increases in computing ... this pace for more than another decade in fact, ...
... N.J., March 28 Pharmasset, Inc.,(Nasdaq: VRUS ) ... Finance under an existing working capital loan agreement that,was ... loan,of $10 million in October 2007 and, at its ... November 30, 2008, provided certain conditions are,satisfied., "We ...
... Networking ... And Expo Event, ... ( ) has announced,that Merck & Co., Inc. will serve as ... May 19-20 at the Westin,Governors in Morristown, N.J. The two-day event ...
Cached Biology Technology:
(Date:9/29/2015)... 29, 2015  iDAvatars is excited to be named one ... to market. The official announcement was recently made at an ... in San Francisco , where iDAvatars presented ... IBM Watson. "It is both an honor and ... to bring to market the cognitive power of IBM Watson ...
(Date:9/28/2015)... Synaptics Inc. (NASDAQ: SYNA ), the ... Lenovo has selected Synaptics , Natural ID ™ ... smartphone, the Vibe P1. The new Vibe P1 ... and provide swift access to applications and mobile payments ... FS4202 sensor solution utilizes AES256-bit encryption of the fingerprint ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
Breaking Biology News(10 mins):
... change their tune in response to urban noise? It depends ... from the Universidad Nacional Autnoma de Mxico and colleagues. Their ... in noisy conditions by means of frequency changes, others like ... in song lengths. The work is published online in Springer,s ...
... you are among the 50 percent of Americans who suffer ... warm milk to melatonin pills or prescription medications to induce ... But what if sleep could be achieved not by a ... Wake Forest Baptist Medical Center have conducted a pilot clinical ...
... Future Science Brief presents a roadmap for marine biodiversity ... ocean provides 95% of the habitable space on Earth ... the health of the oceans and their productive ecosystems ... marine life is under significant threat from climate change ...
Cached Biology News:
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
Synaptotagmin, phosphoSer309...
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
Biology Products: